PET imaging of neuroinflammation in a rat traumatic brain injury model with radiolabeled TSPO ligand DPA-714
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
PurposeThe inflammatory response in injured brain parenchyma after traumatic brain injury (TBI) is crucial in the pathological process. In order to follow microglia activation and neuroinflammation after TBI, we performed PET imaging in a rat model of TBI using 18F-labeled DPA-714, a ligand of the 18-kDa translocator protein (TSPO).MethodsTBI was induced in male SD rats by a controlled cortical impact. The success of the TBI model was confirmed by MRI. [18F]DPA-714 was synthesized using a slightly modified TRACERLab FX-FN module and an automated procedure. In vivo PET imaging was performed at different time points after surgery using an Inveon small-animal PET scanner. The specificity of [18F]DPA-714 was confirmed by a displacement study with an unlabeled competitive TSPO ligand, PK11195. Ex vivo autoradiography as well as immunofluorescence staining was carried out to confirm the in vivo PET results.ResultsBoth in vivo T2-weighted MR images and ex vivo TTC staining results revealed successful establishment of the TBI model. Compared with the sham-treated group, [18F]DPA-714 uptake was significantly higher in the injured brain area on PET images. Increased lesion-to-normal ratios of [18F]DPA-714 were observed in the brain of TBI rats on day 2 after surgery. Ratios peaked around day 6 (2.65 ± 0.36) and then decreased gradually to nearly normal levels on day 28. The displacement study using PK11195 confirmed the specific binding of [18F]DPA-714 to TSPO. The results of ex vivo autoradiography were consistent with in vivo PET results. Immunofluorescence staining showed the time course of TSPO expression after TBI and the temporal and the spatial distribution of microglia in the damaged brain area.ConclusionTSPO-targeted PET using [18F]DPA-714 as the imaging probe can be used to dynamically monitor the inflammatory response after TBI in a noninvasive manner. This method will not only facilitate a better understanding of the inflammatory process after TBI, but also provide a useful in vivo monitoring strategy for antiinflammation therapy of TBI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · cited 1×
“The inflammatory reaction after TBI is a double-edged sword and the detrimental effects of neuroinflammation on the injured brain have been well recognized [4].”
BackgroundMicroglial cell origin and phenotypes in health and disease
Saijo, K., & Glass, C. K. (2011) · Nature Reviews Immunology · doi:10.1038/nri3086 · Cited by 1,100 · cited 1×
“As a primary safeguard in brain homogenesis, microglia undergo a shift in morphology as well as function once the brain is under pathological conditions including TBI [6].”
BackgroundMICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES
González-Scarano, F., & Baltuch, G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.219 · Cited by 984 · cited 1×
“Activatedmicroglia are involved in tissue repair, amplification of inflammatory effects and neuronal degeneration, and the functional state of microglia may, to some extent, reflect the status of the immune reaction in the brain [5, 7].”
BackgroundBlood–brain barrier breakdown as a therapeutic target in traumatic brain injury
Shlosberg, D., Benifla, M., Kaufer, D., & Friedman, A. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.74 · Cited by 897 · cited 1×
“It could also be induced by nonspecific leakage and retention of [(18)F]DPA-714 due to edema and blood– brain barrier disruption after TBI [30].”
BackgroundNeuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention
Kumar, A., & Loane, D. J. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.008 · Cited by 710 · cited 1×
“subsequent cascade of metabolic, cellular and molecular events, which is a result of biochemical derangements such as glutamate excitotoxicity, enhanced levels of free radicals, neuroinflammation and apoptosis [2].”
BackgroundCeulemans, A.-G., Zgavc, T., Kooijman, R., Hachimi-Idrissi, S., Sarre, S., & Michotte, Y. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-74 · Cited by 351 · cited 1×
“Among the biochemical derangements, neuroinflammation is a key pathological response to brain injury and is characterized by glial cell activation including microglia and astrocytes, peripheral leukocyte and macrophage infiltration, and upregulation of proinflammatory mediators [3].”
BackgroundSchilling, M., Besselmann, M., Müller, M., Strecker, J. K., Ringelstein, E. B., & Kiefer, R. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.08.004 · Cited by 288
Evaluation of the PBR/TSPO Radioligand [ 18 F]DPA-714 in a Rat Model of Focal Cerebral Ischemia
Martín, A., Boisgard, R., Thézé, B., Van Camp, N., Kuhnast, B., Damont, A., Kassiou, M., Dollé, F., & Tavitian, B. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.205 · Cited by 206 · cited 2×
“Therefore, [(18)F]DPA-714 has been used for PET imaging of neuroinflammation in different models [9, 17, 21].”
BackgroundMethodJi, B., Maeda, J., Sawada, M., Ono, M., Okauchi, T., Inaji, M., Zhang, M.-R., Suzuki, K., Ando, K., Staufenbiel, M., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2312-08.2008 · Cited by 169 · cited 1×
“Consequently, neuroinflammation in several models of central nervous diseases, such as brain tumor [8], stroke [9] and Alzheimer’s disease [10], has been evaluated by PETusing imaging probes targeting the 18-kDa translocator protein (TSPO).”
BackgroundPK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET
Venneti, S., Lopresti, B. J., Wang, G., Hamilton, R. L., Mathis, C. A., Klunk, W. E., Apte, U. M., & Wiley, C. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.005 · Cited by 138
Cited by
Microglial Activation in Traumatic Brain Injury
Donat, C. K., Scott, G., Gentleman, S. M., & Sastre, M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00208 · Cited by 480
Wang, Y.-L., Han, Q.-Q., Gong, W.-Q., Pan, D.-H., Wang, L.-Z., Hu, W., Yang, M., Li, B., Yu, J., & Liu, Q. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1054-3 · Cited by 438
Self-citationTSPO in diverse CNS pathologies and psychiatric disease: a critical review and a way forward
Guilarte, T. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.003 · Cited by 173
A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis
Nutma, E., Stephenson, J. A., Gorter, R. P., de Bruin, J., Boucherie, D. M., Donat, C. K., Breur, M., van der Valk, P., Matthews, P. M., Owen, D. R., et al. (2019) · Brain · doi:10.1093/brain/awz287 · Cited by 138
“…, 2007; Arlicot et al. , 2008; Ji et al. , 2008; Mattner et al. , 2011; Lavisse et al. , 2012 b ; Daugherty et al. , 2013; Dickens et al. , 2014; Wang et al. , 2014; Lavisse et al. , 2015; Se´rrie`re et al. , 2015; Domene et al. , 2016; Israel et al. , 2016; Nguyen et al. , 2018), only a few…”
Liu, B., Le, K. X., Park, M.-A., Wang, S., Belanger, A. P., Dubey, S., Frost, J. L., Holton, P., Reiser, V., Jones, P. A., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0996-15.2015 · Cited by 114
“…autoimmune encephalomyelitis (Abourbeh et al., 2012; Mattner et al., 2013), multiple sclerosis (Takano et al., 2013), stroke (Boutin et al., 2013; Lartey et al., 2014), and traumatic brain injury (Wang et al., 2014), but also during normal aging (Gulyás et al., 2011; Varrone et al., 2013).”
Background
Metadata
- Authors
- Wang, Y., Yue, X., Kiesewetter, D. O., Niu, G., Teng, G., & Chen, X.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2014-03-11
- Volume
- 41
- Issue
- 7
- Pages
- 1440-1449
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2072171721
- Cited by
- 71
- References
- 10
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.